Evidence map›Paper›PMID 26022965›Full record

Trial reportThe European respiratory journal2015

The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease.

Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A Rabinovich, Nicholas S Hopkinson, Michael I Polkey, Ioannis Vogiatzis, Maggie Tabberer and 12 more

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The European respiratory journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 67 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01388218 completednot on this map

Non-interventional Cross-over Study to Reduce Items of the Draft PROactive Tools as a Measure of Physical Activity in Daily Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

TypeobservationalSponsorBarcelona Institute for Global HealthRan2011 to 2012Enrolled236ConditionsChronic Obstructive Pulmonary Disease (COPD)
NCT04522778 naterminatednot on this mapstarted 2020, after this paper: background citation

Innovative Central Line Securement Device: Line Complications and Quality of Life in the Pediatric Population as Compared to Traditional Securement Device

TypeinterventionalSponsorRyan St. Pierre-HetzRan2020 to 2023Enrolled23ConditionsCentral Line Complication, Central Line Infection, Central Line-Associated Infection, Central Line SepsisArmsWearable Central Line Securement Device (Vest), Traditional Securement Dressing
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Communication About Sexuality (COSY) Encourages Physical Activity in COPD: A Randomised Trial.International journal of chronic obstructive pulmonary disease · 2025
    Trial
  8. Personalised Health Behaviour Support Programme in Adults With Post-COVID Syndrome: A Randomised, Controlled Pilot Feasibility Trial.Health expectations : an international journal of public participation in health care and health policy · 2024
    Trial
  9. Trial
  10. Lung volume reduction surgeryThe European respiratory journal · 2023
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Elena Gimeno-SantosCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, Spain.
Yogini RasteNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK.
Heleen DemeyerDepartment of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, Belgium.
Zafeiris LouvarisDepartment of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, Greece.
Corina de JongDepartment of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Roberto A RabinovichELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Nicholas S HopkinsonNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK.ORCID http://orcid.org/0000-0003-3235-0454
Michael I PolkeyNational Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UK.
Ioannis VogiatzisDepartment of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, Greece.
Maggie TabbererValue Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UK.
Fabienne DobbelsHealth Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.
Nathalie IvanoffAlmirall S.A., Barcelona, Spain.
Willem I de BoerLung Foundation Netherlands, Amersfoort, The Netherlands.
Thys van der MolenDepartment of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Karoly KulichPRO Expert, Novartis Pharma, Basel, Switzerland.
Ignasi SerraCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Xavier BasagañaCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Thierry TroostersDepartment of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, Belgium.
Milo A PuhanEpidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Niklas KarlssonHealth Economics and Outcomes Research, AstraZeneca R&D, Mölndal, Sweden.
Judith Garcia-AymerichCentre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain jgarcia@creal.cat.
PROactive consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No current patient-centred instrument captures all dimensions of physical activity in chronic obstructive pulmonary disease (COPD). Our objective was item reduction and initial validation of two instruments to measure physical activity in COPD.Physical activity was assessed in a 6-week, randomised, two-way cross-over, multicentre study using PROactive draft questionnaires (daily and clinical visit versions) and two activity monitors. Item reduction followed an iterative process including classical and Rasch model analyses, and input from patients and clinical experts.236 COPD patients from five European centres were included. Results indicated the concept of physical activity in COPD had two domains, labelled "amount" and "difficulty". After item reduction, the daily PROactive instrument comprised nine items and the clinical visit contained 14. Both demonstrated good model fit (person separation index >0.7). Confirmatory factor analysis supported the bidimensional structure. Both instruments had good internal consistency (Cronbach's α>0.8), test-retest reliability (intraclass correlation coefficient ≥0.9) and exhibited moderate-to-high correlations (r>0.6) with related constructs and very low correlations (r<0.3) with unrelated constructs, providing evidence for construct validity.Daily and clinical visit "PROactive physical activity in COPD" instruments are hybrid tools combining a short patient-reported outcome questionnaire and two activity monitor variables which provide simple, valid and reliable measures of physical activity in COPD patients.

Indexed as

Motor ActivityAgedAlgorithmsCross-Over StudiesEuropeFactor Analysis, StatisticalFemaleHumansMaleMiddle AgedPsychometricsPulmonary Disease, Chronic ObstructiveQuality of LifeReproducibility of ResultsSeverity of Illness IndexSurveys and Questionnaires

Identifiers

PMID26022965
PMCPMC4589432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.